{"disease":{"id":"von-willebrand-disease","name":"von willebrand disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06820515","title":"ATHNdataset Registry","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200000,"lead_sponsor_name":"American Thrombosis and Hemostasis Network","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT03875924","title":"REAL-LIFE DATA OF CONSTITUTIONAL VON WILLEBRAND DISEASE IN WESTERN FRANCE (HOPSCOTcH-WILL)","phase":"","overall_status":"COMPLETED","enrollment_count":926,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04887324","title":"Real-life Data of Constitutional Von Willebrand Disease in Western France","phase":"","overall_status":"COMPLETED","enrollment_count":922,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT02869074","title":"Molecular and Clinical Profile of Von Willebrand Disease in Spain","phase":"","overall_status":"COMPLETED","enrollment_count":790,"lead_sponsor_name":"Spanish Society of Thrombosis and Haemostasis","has_results":false},{"nct_id":"NCT06064643","title":"The Lived Experience of People With Von Willebrand Disease","phase":"","overall_status":"COMPLETED","enrollment_count":611,"lead_sponsor_name":"Haemnet","has_results":false},{"nct_id":"NCT04119908","title":"Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT03621020","title":"Clinical Performance Evaluation of T-TAS 01 PL Chip","phase":"","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Hikari Dx, Inc.","has_results":false},{"nct_id":"NCT02460458","title":"Type 3 Von Willebrand International Registries Inhibitor Prospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"Fondazione Angelo Bianchi Bonomi","has_results":true},{"nct_id":"NCT03070912","title":"Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients","phase":"","overall_status":"COMPLETED","enrollment_count":257,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT04657887","title":"Registry of Patients With Von WilLEbrand Disease Treated With Voncento®","phase":"","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT06710262","title":"T-TAS® wS Method Comparison","phase":"","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Hikari Dx, Inc.","has_results":false},{"nct_id":"NCT03853486","title":"ATHN 9: Severe VWD Natural History Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":108,"lead_sponsor_name":"American Thrombosis and Hemostasis Network","has_results":false},{"nct_id":"NCT05265078","title":"A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD) Treated With Veyvondi","phase":"","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04106323","title":"A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Safaa AA Khaled","has_results":false},{"nct_id":"NCT05773638","title":"Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04281771","title":"Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":92,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04810702","title":"Impact of Von Willebrand Factor and Its Multimers on Angiogenesis","phase":"","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT06998524","title":"A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT02792205","title":"Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT03613584","title":"Von Willebrand Factor Concentrate During ECMO Support","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":68,"lead_sponsor_name":"Tirol Kiniken GmbH","has_results":false},{"nct_id":"NCT04053699","title":"Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Octapharma","has_results":true},{"nct_id":"NCT04466878","title":"Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleeding","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT04849338","title":"The Role of Standardized Bleeding Score in Diagnosis of Pediatric Von Willebrand's Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT01410227","title":"Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT07358013","title":"Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects","phase":"","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT03078595","title":"Gingival Bleeding and Von Willebrand Disease Typ 2 and 3","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Goethe University","has_results":true},{"nct_id":"NCT04052698","title":"Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Octapharma","has_results":true},{"nct_id":"NCT06883240","title":"An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT02606045","title":"Minimize Menorrhagia in Women With Von Willebrand Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":39,"lead_sponsor_name":"Margaret Ragni","has_results":true},{"nct_id":"NCT03879135","title":"A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT06433778","title":"A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)","phase":"","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT00816660","title":"Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT02932618","title":"A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":31,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT02973087","title":"rVWF IN PROPHYLAXIS","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT06064851","title":"Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Five Liters, Inc.","has_results":false},{"nct_id":"NCT02552576","title":"Study of Voncento® in Subjects With Von Willebrand Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT04677803","title":"BT200 in Hereditary Bleeding Disorders","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT05582993","title":"A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT02283268","title":"Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT07129343","title":"A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04344860","title":"Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Nicoletta C Machin","has_results":true},{"nct_id":"NCT03915873","title":"Evaluation of Bleeding Score in Egyptian Patients With vWD Type I and Correlate it With Laboratory Parameters","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07404644","title":"An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)","phase":"","overall_status":"RECRUITING","enrollment_count":13,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04953884","title":"Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Octapharma","has_results":true},{"nct_id":"NCT05695560","title":"A Survey to Describe the Experience and Unmet Needs of Persons Living With Von Willebrand Disease (VWD) and Their Caregivers","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04770935","title":"To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Bioverativ, a Sanofi company","has_results":false},{"nct_id":"NCT07273721","title":"Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT06173024","title":"Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Takeda","has_results":false}],"total":49},"guidelines":[],"source":"Drug Landscape verified database"}